| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
20,770 |
18,734 |
$728K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
11,558 |
9,795 |
$610K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,337 |
1,018 |
$283K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
8,299 |
4,198 |
$105K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,323 |
2,214 |
$86K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
12,090 |
9,716 |
$82K |
| 87430 |
|
3,792 |
3,546 |
$59K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,668 |
1,516 |
$42K |
| 80053 |
Comprehensive metabolic panel |
5,164 |
4,056 |
$42K |
| 87081 |
|
2,721 |
2,557 |
$27K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
1,538 |
303 |
$21K |
| 81001 |
|
5,326 |
4,381 |
$17K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
134 |
128 |
$15K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,111 |
1,698 |
$13K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
331 |
271 |
$12K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
304 |
254 |
$12K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
195 |
166 |
$10K |
| 71045 |
Radiologic examination, chest; single view |
2,238 |
1,869 |
$9K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
72 |
53 |
$9K |
| 87420 |
|
517 |
495 |
$9K |
| 70450 |
Computed tomography, head or brain; without contrast material |
148 |
116 |
$9K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,097 |
864 |
$8K |
| 71046 |
Radiologic examination, chest; 2 views |
827 |
708 |
$7K |
| 83735 |
|
1,200 |
882 |
$6K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
298 |
291 |
$5K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
621 |
517 |
$5K |
| 59025 |
Fetal non-stress test |
1,010 |
704 |
$5K |
| 84443 |
Thyroid stimulating hormone (TSH) |
229 |
215 |
$3K |
| 84484 |
|
662 |
436 |
$3K |
| 81025 |
|
834 |
731 |
$2K |
| 87634 |
|
37 |
37 |
$2K |
| 83690 |
|
453 |
364 |
$2K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
192 |
186 |
$2K |
| 81003 |
|
909 |
768 |
$2K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
17 |
13 |
$2K |
| 80061 |
Lipid panel |
127 |
123 |
$2K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,520 |
1,255 |
$2K |
| 82607 |
|
110 |
105 |
$2K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
103 |
29 |
$2K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
407 |
86 |
$1K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
181 |
172 |
$1K |
| 86140 |
|
428 |
394 |
$951.06 |
| 82746 |
|
66 |
63 |
$839.96 |
| 86376 |
|
44 |
44 |
$737.88 |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
17 |
13 |
$625.68 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,937 |
1,585 |
$596.50 |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
98 |
25 |
$576.18 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
62 |
38 |
$542.50 |
| 84403 |
|
13 |
12 |
$498.63 |
| 83655 |
|
29 |
27 |
$452.10 |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
27 |
13 |
$384.36 |
| 80076 |
|
87 |
70 |
$376.20 |
| 82553 |
|
95 |
56 |
$340.20 |
| 82248 |
|
115 |
81 |
$329.85 |
| 82728 |
|
28 |
28 |
$266.40 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
383 |
316 |
$251.86 |
| 85027 |
|
134 |
111 |
$251.76 |
| 84479 |
|
43 |
43 |
$233.97 |
| 82550 |
|
96 |
57 |
$201.60 |
| 84436 |
|
43 |
43 |
$175.23 |
| 83605 |
|
15 |
12 |
$148.00 |
| 86038 |
|
15 |
15 |
$134.56 |
| 85651 |
|
39 |
39 |
$104.40 |
| 87077 |
|
19 |
12 |
$98.78 |
| 82247 |
|
30 |
25 |
$87.30 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
27 |
25 |
$81.60 |
| 84460 |
|
13 |
12 |
$66.51 |
| 85007 |
|
13 |
12 |
$65.91 |
| 84450 |
|
13 |
12 |
$60.48 |
| 93017 |
|
12 |
12 |
$56.12 |
| 85018 |
|
15 |
15 |
$52.05 |
| 85014 |
|
15 |
15 |
$52.05 |
| 85652 |
|
29 |
26 |
$51.61 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
634 |
524 |
$51.24 |
| 86850 |
|
31 |
25 |
$34.98 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
29 |
16 |
$27.90 |
| 36415 |
Collection of venous blood by venipuncture |
2,833 |
2,321 |
$19.36 |
| 86900 |
|
32 |
26 |
$16.31 |
| 86901 |
|
32 |
26 |
$16.16 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
853 |
648 |
$2.61 |
| J2704 |
Injection, propofol, 10 mg |
176 |
122 |
$0.44 |
| A9270 |
Non-covered item or service |
638 |
420 |
$0.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
170 |
109 |
$0.00 |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
76 |
24 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
18 |
12 |
$0.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
65 |
56 |
$0.00 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
840 |
657 |
$0.00 |
| C1780 |
Lens, intraocular (new technology) |
72 |
53 |
$0.00 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
34 |
25 |
$0.00 |
| J7510 |
Prednisolone oral, per 5 mg |
17 |
16 |
$0.00 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
34 |
25 |
$0.00 |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
12 |
12 |
$0.00 |